Israel-based medical device company Brainsway has received an investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to evaluate the efficacy of its Deep TMS device in multi-center smoking cessation study. ...
Tags: Smoking Cessation Study, Health, Medicine
Medical devices developer Brainsway has reported positive final results from a double-blind, placebo-controlled study, designed to assess the therapeutic efficacy of its Deep TMS device in treating obsessive-compulsive disorder (OCD) using ...
Tags: Medical devices, Brainsway
Brainsway has gained US marketing rights for its Deep transcranial magnetic stimulation (TMS) device, designed for use in patients with depression, who have failed to respond to antidepressant medications, following the US Food and Drug ...
Brainsway has started the multicenter clinical trial of its Deep TMS device, designed to treat various neurological and psychopathological disorders. Noninvasive Deep TMS device has also the potential to treat schizophrenia, obesity, ...
Tags: Brainsway, Deep TMS device, Parkinson's disease, Alzheimer's disease